Table of contents

Inflammatory bowel disease

• Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn’s disease (18 December, 2003)

  A Di Sabatino, R Ciccocioppo, B Cinque, D Millimaggi, R Morera, L Ricevuti, M G Cifone, G R Corazza
• Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor

  (18 December, 2003)

  D Jung, A C Fantin, U Scheurer, M Fried, G A Kullak-Ublick
• Reversal of abnormal collagen production in Crohn’s disease intestinal biopsies treated with regenerating agents (18 December, 2003)

  C Alexakis, J P Caruelle, A Sezeur, J Cosnes, J P Gendre, H Mosnier, L Beaugerie, D Gallot, M Malafosse, D Barritault, P Kern
• Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn’s disease differentially activate the innate immune response (18 December, 2003)

  E Furrie, S Macfarlane, J H Cummings, G T Macfarlane
• Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats

  (18 December, 2003)

  T G Moreels, R J Nieuwendijk, J G De Man, B Y De Winter, A G Herman, E A Van Marck, P A Pelckmans
• Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis (18 December, 2003)

  T Mimura, F Rizzello, U Helwig, G Poggioli, S Schreiber, I C Talbot, R J Nicholls, P Gionchetti, M Campieri, M A Kamm